Cargando…
Distinct Clinical Features and Novel Mutations in Taiwanese Patients With X-Linked Agammaglobulinemia
Background: X-linked agammaglobulinemia (XLA) is caused by a mutation of the Bruton's tyrosine kinase (BTK) gene and is the most common genetic mutation in patients with congenital agammaglobulinemia. The aim of this study was to analyze the clinical features, genetic defects, and/or BTK expres...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7498534/ https://www.ncbi.nlm.nih.gov/pubmed/33013854 http://dx.doi.org/10.3389/fimmu.2020.02001 |
_version_ | 1783583531610406912 |
---|---|
author | Yeh, Yu-Hsin Hsieh, Meng-Ying Lee, Wen-I Huang, Jing-Long Chen, Li-Chen Yeh, Kuo-Wei Ou, Liang-Shiou Yao, Tsung-Chieh Wu, Chao-Yi Lin, Syh-Jae |
author_facet | Yeh, Yu-Hsin Hsieh, Meng-Ying Lee, Wen-I Huang, Jing-Long Chen, Li-Chen Yeh, Kuo-Wei Ou, Liang-Shiou Yao, Tsung-Chieh Wu, Chao-Yi Lin, Syh-Jae |
author_sort | Yeh, Yu-Hsin |
collection | PubMed |
description | Background: X-linked agammaglobulinemia (XLA) is caused by a mutation of the Bruton's tyrosine kinase (BTK) gene and is the most common genetic mutation in patients with congenital agammaglobulinemia. The aim of this study was to analyze the clinical features, genetic defects, and/or BTK expression in patients suspected of having XLA who were referred from the Taiwan Foundation of Rare Disorders (TFRD). Methods: Patients with recurrent bacterial infections in the first 2 years of life, serum IgG/A/M below 2 standard deviations of the normal range, and ≦2% CD19+B cells were enrolled during the period of 2004–2019. The frequency of infections, pathogens, B-lymphocyte subsets, and family pedigree were recorded. Peripheral blood samples were sent to our institute for BTK expression and genetic analysis. Results: Nineteen (from 16 families) out of 29 patients had BTK mutations, including 7 missense mutations, 7 splicing mutations, 1 nonsense mutation, 2 huge deletions, and 2 nucleotide deletions. Six novel mutations were detected: c.504G>T [p.K168N], c.895-2A>G [p.Del K290 fs 23(*)], c.910T>G [p.F304V], c.1132T>C [p.T334H], c.1562A>T [p.D521V], and c.1957delG [Del p.D653 fs plus 45 a.a.]. All patients with BTK mutations had obviously decreased BTK expressions. Pseudomonas sepsis developed in 14 patients and led to both Shanghai fever and recurrent hemophagocytic lymphohistiocytosis (HLH). Recurrent sinopulmonary infections and bronchiectasis occurred in 11 patients. One patient died of pseudomonas sepsis and another died of hepatocellular carcinoma before receiving optimal treatment. Two patients with contiguous gene deletion syndrome (CGS) encompassing the TIMM8A/DDP1 gene presented with early-onset progressive post-lingual sensorineural Deafness, gradual Dystonia, and Optic Neuronopathy syndrome (DDON) or Mohr-Tranebjaerg syndrome (MTS). Conclusion: Pseudomonas sepsis was more common (74%) than recurrent sinopulmonary infections in Taiwanese XLA patients, and related to Shanghai fever and recurrent HLH, both of which were prevented by regular immunoglobulin infusions. Approximately 10% of patients belonged to CGS involving the TIMM8A/DDP1 gene and presented with the DDON/MTS phenotype in need of aggressive psychomotor therapy. |
format | Online Article Text |
id | pubmed-7498534 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-74985342020-10-02 Distinct Clinical Features and Novel Mutations in Taiwanese Patients With X-Linked Agammaglobulinemia Yeh, Yu-Hsin Hsieh, Meng-Ying Lee, Wen-I Huang, Jing-Long Chen, Li-Chen Yeh, Kuo-Wei Ou, Liang-Shiou Yao, Tsung-Chieh Wu, Chao-Yi Lin, Syh-Jae Front Immunol Immunology Background: X-linked agammaglobulinemia (XLA) is caused by a mutation of the Bruton's tyrosine kinase (BTK) gene and is the most common genetic mutation in patients with congenital agammaglobulinemia. The aim of this study was to analyze the clinical features, genetic defects, and/or BTK expression in patients suspected of having XLA who were referred from the Taiwan Foundation of Rare Disorders (TFRD). Methods: Patients with recurrent bacterial infections in the first 2 years of life, serum IgG/A/M below 2 standard deviations of the normal range, and ≦2% CD19+B cells were enrolled during the period of 2004–2019. The frequency of infections, pathogens, B-lymphocyte subsets, and family pedigree were recorded. Peripheral blood samples were sent to our institute for BTK expression and genetic analysis. Results: Nineteen (from 16 families) out of 29 patients had BTK mutations, including 7 missense mutations, 7 splicing mutations, 1 nonsense mutation, 2 huge deletions, and 2 nucleotide deletions. Six novel mutations were detected: c.504G>T [p.K168N], c.895-2A>G [p.Del K290 fs 23(*)], c.910T>G [p.F304V], c.1132T>C [p.T334H], c.1562A>T [p.D521V], and c.1957delG [Del p.D653 fs plus 45 a.a.]. All patients with BTK mutations had obviously decreased BTK expressions. Pseudomonas sepsis developed in 14 patients and led to both Shanghai fever and recurrent hemophagocytic lymphohistiocytosis (HLH). Recurrent sinopulmonary infections and bronchiectasis occurred in 11 patients. One patient died of pseudomonas sepsis and another died of hepatocellular carcinoma before receiving optimal treatment. Two patients with contiguous gene deletion syndrome (CGS) encompassing the TIMM8A/DDP1 gene presented with early-onset progressive post-lingual sensorineural Deafness, gradual Dystonia, and Optic Neuronopathy syndrome (DDON) or Mohr-Tranebjaerg syndrome (MTS). Conclusion: Pseudomonas sepsis was more common (74%) than recurrent sinopulmonary infections in Taiwanese XLA patients, and related to Shanghai fever and recurrent HLH, both of which were prevented by regular immunoglobulin infusions. Approximately 10% of patients belonged to CGS involving the TIMM8A/DDP1 gene and presented with the DDON/MTS phenotype in need of aggressive psychomotor therapy. Frontiers Media S.A. 2020-09-04 /pmc/articles/PMC7498534/ /pubmed/33013854 http://dx.doi.org/10.3389/fimmu.2020.02001 Text en Copyright © 2020 Yeh, Hsieh, Lee, Huang, Chen, Yeh, Ou, Yao, Wu and Lin. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Yeh, Yu-Hsin Hsieh, Meng-Ying Lee, Wen-I Huang, Jing-Long Chen, Li-Chen Yeh, Kuo-Wei Ou, Liang-Shiou Yao, Tsung-Chieh Wu, Chao-Yi Lin, Syh-Jae Distinct Clinical Features and Novel Mutations in Taiwanese Patients With X-Linked Agammaglobulinemia |
title | Distinct Clinical Features and Novel Mutations in Taiwanese Patients With X-Linked Agammaglobulinemia |
title_full | Distinct Clinical Features and Novel Mutations in Taiwanese Patients With X-Linked Agammaglobulinemia |
title_fullStr | Distinct Clinical Features and Novel Mutations in Taiwanese Patients With X-Linked Agammaglobulinemia |
title_full_unstemmed | Distinct Clinical Features and Novel Mutations in Taiwanese Patients With X-Linked Agammaglobulinemia |
title_short | Distinct Clinical Features and Novel Mutations in Taiwanese Patients With X-Linked Agammaglobulinemia |
title_sort | distinct clinical features and novel mutations in taiwanese patients with x-linked agammaglobulinemia |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7498534/ https://www.ncbi.nlm.nih.gov/pubmed/33013854 http://dx.doi.org/10.3389/fimmu.2020.02001 |
work_keys_str_mv | AT yehyuhsin distinctclinicalfeaturesandnovelmutationsintaiwanesepatientswithxlinkedagammaglobulinemia AT hsiehmengying distinctclinicalfeaturesandnovelmutationsintaiwanesepatientswithxlinkedagammaglobulinemia AT leeweni distinctclinicalfeaturesandnovelmutationsintaiwanesepatientswithxlinkedagammaglobulinemia AT huangjinglong distinctclinicalfeaturesandnovelmutationsintaiwanesepatientswithxlinkedagammaglobulinemia AT chenlichen distinctclinicalfeaturesandnovelmutationsintaiwanesepatientswithxlinkedagammaglobulinemia AT yehkuowei distinctclinicalfeaturesandnovelmutationsintaiwanesepatientswithxlinkedagammaglobulinemia AT ouliangshiou distinctclinicalfeaturesandnovelmutationsintaiwanesepatientswithxlinkedagammaglobulinemia AT yaotsungchieh distinctclinicalfeaturesandnovelmutationsintaiwanesepatientswithxlinkedagammaglobulinemia AT wuchaoyi distinctclinicalfeaturesandnovelmutationsintaiwanesepatientswithxlinkedagammaglobulinemia AT linsyhjae distinctclinicalfeaturesandnovelmutationsintaiwanesepatientswithxlinkedagammaglobulinemia |